← Back to Clinical Trials
Recruiting NCT06339957

NCT06339957 Rheumatology Diet Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06339957
Status Recruiting
Phase
Sponsor University of Central Florida
Condition Diet Habit
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2024-03-01
Primary Completion 2025-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500 participants in total. It began in 2024-03-01 with a primary completion date of 2025-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to collect information on rheumatology patients' dietary habits, autoimmune disease activity, dietary changes, disease symptom improvements, and perceptions on their dietary habits and how it affects their autoimmune disease. The main objective is to see if rheumatology patients change their dietary habits after their diagnosis of an autoimmune disease and if it subjectively improved their disease symptoms. It will also look at rheumatology patients' expectations for their rheumatologist when it comes to dietary advice and what resources they used to choose their new dietary habits. The study also seeks to measure the interest that rheumatology patients have in pursuing dietary changes as a means of controlling the symptoms of their autoimmune disease. It is expected that patients who changed their eating habits to healthier diets such as a Mediterranean diet would report less severe autoimmune disease symptoms. There are limited dietary recommendations for the management of many rheumatological diseases, so this study seeks to assess rheumatology patients' willingness to try dietary modifications, what improvements they had, and why they decide to make these changes in light of limited information.

Eligibility Criteria

Inclusion Criteria: * Adults (over 18 years old) patients * established UCF Health patients * diagnosed with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, dermatomyositis/polymyositis, Sjogren's Syndrome, systemic lupus erythematous, scleroderma, osteoarthritis, or fibromyalgia. Exclusion Criteria: * UCF Students, Faculty or Staff * Children or Young Adults Under the age of 18 * Adults over 65 * Pregnant Women * Prisoners * Adults to Unable to Consent

Contact & Investigator

Central Contact

Amoy Fraser, PhD, CCRP, PMP

✉ amoy.fraser@ucf.edu

📞 407-266-8742

Principal Investigator

Neha Bhanusali, MD

PRINCIPAL INVESTIGATOR

University of Central Florida

Frequently Asked Questions

Who can join the NCT06339957 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Diet Habit. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06339957 currently recruiting?

Yes, NCT06339957 is actively recruiting participants. Contact the research team at amoy.fraser@ucf.edu for enrollment information.

Where is the NCT06339957 trial being conducted?

This trial is being conducted at Orlando, United States.

Who is sponsoring the NCT06339957 clinical trial?

NCT06339957 is sponsored by University of Central Florida. The principal investigator is Neha Bhanusali, MD at University of Central Florida. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology